藤丸拓也

フジマルタクヤ | Fujimaru Takuya

研究分野 (1件)：腎臓内科学

競争的資金等の研究課題 (2件)：

論文 (23件)：

Takahashi N, Kikuchi H, Usui A, Furusho T, Fujimaru T, Fujiki T, Yanagi T, Matsuura Y, Asano K, Yamamoto K, et al. Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD₂ in the kidney. Clinical and experimental nephrology. 2021. 25. 5. 445-455
Mori Takayasu, Chiga Motoko, Fujimaru Takuya, Kawamoto Ryosuke, Mandai Shintaro, Nanamatsu Azuma, Nomura Naohiro, Ando Fumiaki, Susa Koichiro, Sohara Eisei, et al. Phenotypic differences of mutation-negative cases in Gitelman syndrome clinically diagnosed in adulthood. HUMAN MUTATION. 2020. 42. 3. 300-309
Sekine Akinari, Hoshino Junichi, Fujimaru Takuya, Suwabe Tatsuya, Mizuno Hiroki, Kawada Masahiro, Hiramatsu Rikako, Hasegawa Eiko, Yamanouchi Masayuki, Hayami Noriko, et al. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. AMERICAN JOURNAL OF NEPHROLOGY. 2020. 51. 9. 745-751
Ishii T, Fujimaru T, Nakano E, Takahashi O, Nakayama M, Yamauchi T, Komatsu Y. Association between chronic kidney disease and mortality in stage IV cancer. International journal of clinical oncology. 2020. 25. 9. 1587-1595
藤丸拓也, 内田信一. 【腎疾患診療の新たな展開】各種腎臓病の診断と治療遺伝性腎疾患. 臨牀と研究. 2020. 97. 6. 682-688

MISC (3件)：

書籍 (1件)：

講演・口頭発表等 (11件)：

Tubular basement membrane duplication and cell interposition are distinctive histological findings in the adult patients genetically diagnosed with NPHP-RCs
(ASN Kidney Week 2019)
「嚢胞性疾患 3」オーバービュー.
(第49回日本腎臓学会東部学術大会,)
腎生検にて NPHP-MCKD complex と診断された成人症例の遺伝的背景.
(第62回日本腎臓学会学術総会.)
Genomic Background of Adults with Suspected Ciliopathy on Renal Biopsy.
(The 52nd Annual Meeting of American Society of Nephrology, Kidney Week 2018)
家族歴のない成人多発性腎嚢胞患者における網羅的遺伝子解析を用いた遺伝子診断と臨床所見の検討
(第61回日本腎臓学会学術集会.)

経歴 (2件)：

受賞 (2件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

藤丸 拓也